Retrophin (RTRX) Q1 2019 Earnings Call Transcript
RTRX earnings call for the period ending March 31, 2019.
Retrophin
RTRX
RTRX
$18.45
-$0.08
-0.4%
BATS BZX Real Time Price as of May 22, 2019, 2:20 p.m.
View Interactive RTRX Charts
Retrophin, Inc.
News & Analysis: Retrophin
All
Market Moves
Earnings
2 Healthcare Stocks With Jaw-Dropping Growth Potential
These two growth stocks are poised for enormous gains.
Retrophin Inc (RTRX) Q4 2018 Earnings Conference Call Transcript
RTRX earnings call for the period ending December 31, 2018.
Why Shares of Retrophin Inc Are Soaring Today
The biopharma's stock skyrocketed in response to strong phase 2 clinical trial results.
Why Raptor Pharmaceutical Corp. Is Clawing Higher Today
Shares pop on rumors of a potential buyout.
Why Retrophin Inc was Down Today
News of an incoming competitor pushed shares lower in early trading.
Martin Shkreli -- "The Most Hated Man in America" -- Is in Handcuffs. Here's Why.
Biotech CEO Martin Shkreli was arrested today on charges of securities fraud.
3 Ways to Avoid Being Duped by a Martin Shkreli Look-Alike
Tips to avoid falling victim to financial fraud.
"Pharma Bro" Martin Shkreli's Day of Reckoning
Federal investigators have arrested the former hedge fund manager for securities fraud.
Why Retrophin's Shares Are Crashing Today
Retrophin finds itself under scrutiny by the Senate over its decision to increase the price of a drug it acquired in 2014.
